REGN
Regeneron Pharmaceuticals Inc
788.00$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.7% | 32.4% | 30.6% | 22.3% | 32.7% | 30.9% | 30.8% | 44.1% | 41.2% | 35.0% | 31.1% | 34.7% | |
| 1.9% | 1.8% | 2.2% | 2.5% | 2.2% | 2.7% | 2.8% | 1.8% | 2.8% | 3.2% | 3.4% | 3.8% | |
| 10.9% | 11.2% | 11.5% | 8.6% | 6.4% | 5.9% | 5.1% | 3.7% | 6.0% | 6.7% | 6.9% | 6.9% | |
| 14.0% | 16.9% | 11.9% | 1.8% | -3.7% | 4.0% | -10.5% | -6.2% | 5.6% | – | – | – | |
| 0.7% | 5.6% | 4.7% | -15.8% | -10.4% | -2.5% | -17.7% | -11.9% | -2.0% | -0.7% | -4.4% | 3.7% | |
| 11.8% | 16.5% | 10.5% | 4.6% | 5.7% | 5.5% | 7.2% | 3.4% | 4.8% | 7.1% | 5.3% | 6.3% | |
| -14.9% | -22.1% | -21.5% | -17.1% | -21.8% | -25.8% | -0.8% | -33.5% | -31.1% | -24.3% | -17.4% | -4.4% | |
| 10.4% | 13.3% | 10.3% | 6.1% | – | – | – | – | – | 0.0% | 0.0% | 2.6% | |
| -9.5% | -3.9% | -2.9% | -5.1% | -2.9% | -5.9% | -76.8% | -16.7% | -20.8% | -17.0% | -25.6% | -27.7% | |
| -7.9% | -3.4% | -0.8% | 0.6% | 29.5% | 25.2% | 23.3% | 0.0% | 0.0% | – | – | – | |
| -7.8% | -6.4% | -14.4% | -0.4% | -1.1% | -3.2% | -23.2% | -6.3% | -8.3% | -13.6% | -15.5% | -25.9% | |
| 4.0% | 3.9% | -5.6% | 4.7% | 9.8% | 1.9% | 6.8% | 4.3% | 1.8% | -2.9% | -1.8% | 4.4% | |
| 14.9% | 15.9% | 20.0% | 17.6% | 27.0% | 25.4% | 23.6% | 40.6% | 36.3% | 28.0% | 25.8% | 28.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.